xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling
- PMID: 32931751
- PMCID: PMC7647670
- DOI: 10.1016/j.ymthe.2020.08.021
"VSports app下载" xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling
Abstract
System xc- cystine/glutamate antiporter, composed of a light-chain subunit (xCT, SLC7A11) and a heavy-chain subunit (CD98hc, SLC3A2), is mainly responsible for the cellular uptake of cystine in exchange for intracellular glutamate. In recent years, the xCT molecule has been found to play an important role in tumor growth, progression, metastasis, and multidrug resistance in various types of cancer VSports手机版. Interestingly, xCT also exhibits an essential function in regulating tumor-associated ferroptosis. Despite significant progress in targeting the system xc- transporter in cancer treatment, the underlying mechanisms still remain elusive. It is also unclear why solid tumors are more sensitive to xCT inhibitors such as sulfasalazine, as compared to hematological malignancies. This review mainly focuses on the role of xCT cystine/glutamate transporter in regard to tumor growth, chemoresistance, tumor-selective ferroptosis, and the mechanisms regulating xCT gene expression. The potential therapeutic implications of targeting the system xc- and its combination with chemotherapeutic agents or immunotherapy to suppress tumor growth and overcome drug resistance are also discussed. .
Keywords: ROS; ferroptosis; system x(c)(−); xCT. V体育安卓版.
Copyright © 2020 The American Society of Gene and Cell Therapy. Published by Elsevier Inc V体育ios版. All rights reserved. .
Figures



References
-
- Okuno S., Sato H., Kuriyama-Matsumura K., Tamba M., Wang H., Sohda S., Hamada H., Yoshikawa H., Kondo T., Bannai S. Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Br. J. Cancer. 2003;88:951–956. - "VSports" PMC - PubMed
-
- Huang Y., Dai Z., Barbacioru C., Sadée W. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res. 2005;65:7446–7454. - "VSports" PubMed
-
- Liu R., Blower P.E., Pham A.N., Fang J., Dai Z., Wise C., Green B., Teitel C.H., Ning B., Ling W. Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin. Mol. Pharmacol. 2007;72:1637–1646. - PubMed
-
- Chen R.S., Song Y.M., Zhou Z.Y., Tong T., Li Y., Fu M., Guo X.L., Dong L.J., He X., Qiao H.X. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway. Oncogene. 2009;28:599–609. - PubMed
-
- Lo M., Wang Y.Z., Gout P.W. The xc− cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J. Cell. Physiol. 2008;215:593–602. - PubMed
Publication types
- "VSports app下载" Actions
V体育官网入口 - MeSH terms
- "V体育官网入口" Actions
- VSports - Actions
- Actions (V体育官网入口)
- "VSports" Actions
- Actions (V体育安卓版)
- "VSports app下载" Actions
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical (V体育平台登录)